Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Avadel Pharmaceuticals Plc (NQ: AVDL )

8.540 USD +0.100 (+1.18%)
Official Closing Price Updated: 4:00 PM EDT, Apr 13, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 260,400
Open 8.450
Bid (Size) 8.360 (1)
Ask (Size) 9.130 (1)
Prev. Close 8.440
Today's Range 8.210 - 8.560
52wk Range 4.830 - 13.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Avadel to Present New Data from its Pivotal REST-ON Phase 3 Study of FT218 at the American Academy of Neurology Annual Meeting 2021
From GlobeNewswire News Releases
Avadel Pharmaceuticals to Participate in a Fireside Chat at Stifel’s Third Annual CNS Day on March 31st
From GlobeNewswire News Releases

Performance

YTD
+28.23%
+28.23%
1 Month
-15.19%
-15.19%
3 Month
+27.08%
+27.08%
6 Month
+53.87%
+53.87%
1 Year
-9.82%
-9.82%

More News

Read More
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
From GlobeNewswire News Releases
Avadel Pharmaceuticals and the American Academy of Sleep Medicine Foundation Announce an Exclusive Collaboration on the 2021 Young Investigators Research Forum
From GlobeNewswire News Releases
Avadel Pharmaceuticals Announces Publication of Once-Nightly FT218 Pharmacokinetic Studies
From GlobeNewswire News Releases
Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for FT218 in Adults with Narcolepsy for the Treatment of Excessive Daytime Sleepiness and Cataplexy
From GlobeNewswire News Releases
Avadel Pharmaceuticals to Participate in Fireside Chats at Upcoming March 2021 Investor Conferences
From GlobeNewswire News Releases
Avadel Pharmaceuticals to Provide a Company Update and Report Fourth Quarter and Full Year 2020 Financial Results, on March 9th
From GlobeNewswire News Releases
Avadel Pharmaceuticals Appoints Richard Kim as Chief Commercial Officer to Lead the Commercial Launch of Once-Nightly FT218
From GlobeNewswire News Releases
Avadel Pharmaceuticals to Participate in a Fireside Chat at the 10th Annual SVB Leerink Global Healthcare Conference
From GlobeNewswire News Releases
Avadel Pharmaceuticals Announces Submission of New Drug Application for FT218 to the FDA
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.